DrugPatentWatch Database Preview
Details for Patent: 6,777,423
» See Plans and Pricing
Which drugs does patent 6,777,423 protect, and when does it expire?
Patent 6,777,423 protects SPIRIVA and is included in one NDA.
Protection for SPIRIVA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has sixty-five patent family members in forty-six countries.
Summary for Patent: 6,777,423
| Title: | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions |
| Abstract: | Crystalline monohydrate of (1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)-7-[(hydroxydi-2-thienylacetyl) oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0.sup.2,4 ]nonane bromide (tiotropium bromide monohydrate), processes for the preparation thereof, pharmaceutical compositions thereof, and their use. |
| Inventor(s): | Banholzer; Rolf (Stuttgart, DE), Sieger; Peter (Mittelbiberach, DE), Kulinna; Christian (Mainz, DE), Trunk; Michael (Ingelheim, DE), Graulich; Manfred (Waldalgesheim, DE), Specht; Peter (Ober-Hilbersheim, DE), Meissner; Helmut (Ingelheim, DE), Mathes; Andreas (Ockenheim, DE) |
| Assignee: | Boehringer Ingelheim Pharma KG (Ingelheim, DE) |
| Application Number: | 10/354,521 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,777,423 |
|
Patent Claim Types: see list of patent claims | Compound; Process; |
Drugs Protected by US Patent 6,777,423
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim | SPIRIVA | tiotropium bromide | POWDER;INHALATION | 021395-001 | Jan 30, 2004 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,777,423
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Germany | 100 50 621 | Oct 12, 2000 |
International Family Members for US Patent 6,777,423
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| African Regional IP Organization (ARIPO) | 1572 | Start Trial | |||
| Argentina | 034389 | Start Trial | |||
| Argentina | 068527 | Start Trial | |||
| Austria | 276253 | Start Trial | |||
| Australia | 1499602 | Start Trial | |||
| Australia | 2002214996 | Start Trial | |||
| Bulgaria | 107687 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
